Ichiro Kurakazu

Ichiro Kurakazu

Auto-generated profile, based on publicly available information

Ichiro Kurakazu

Department of Orthopaedic Surgery Kyushu University Fukuoka Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in The Knee
Verified
Journal Article
Closed access
UKUmito Kuwashima
Umito Kuwashima
KIKenyu Iwasaki
Kenyu Iwasaki
IKIchiro Kurakazu
Ichiro Kurakazu
YAYukio Akasaki
Yukio Akasaki
YNYasuharu Nakashima
Yasuharu Nakashima
KOKen Okazaki
Ken Okazaki

21 November 2025 in Osteoarthritis and Cartilage
Verified
Journal Article
Open access
YHYuki Hyodo
Yuki Hyodo
YAYukio Akasaki
Yukio Akasaki
IKIchiro Kurakazu
Ichiro Kurakazu
MKMasanari Kuwahara
Masanari Kuwahara
TUTaisuke Uchida
Taisuke Uchida
YNYasuharu Nakashima
Yasuharu Nakashima
Metformin, a first-line treatment for type 2 diabetes, attenuates hallmarks of aging and protects against age-related diseases, including osteoarthritis (OA). Here, we assessed the effects of imeglimin, a novel antidiabetic drug synthesized from metformin, on the development and progression of knee OA. Primary human OA chondrocytes, synovial cells, and meniscal cells were stimulated with IL-1β and treated with imeglimin (n = 8). OA-related gene and protein expressions were quantified using RT-qPCR and ELISA. Activation of NF-κB and AMP-activated protein kinase (AMPK), a master regulator of energy metabolism, was assessed using western blotting and immunofluorescence. Additionally, we evaluated its efficacy in two knee OA mouse models (n = 10): destabilization of the medial meniscus and medial collateral ligament transection (DMM+MCLT), and monoiodoacetate (MIA)-induced OA pain. Imeglimin suppressed IL-1β-induced expressions of OA-related genes, including pro-inflammatory (IL6, IL1B, TNF), catabolic (MMP13, ADAMTS5), and pain-related (CCL2, NGF) genes, and reduced IL6 secretion. Western blot analysis revealed downregulation of IκBα and p65 activation and AMPK upregulation. Immunocytochemistry confirmed decreased p65 nuclear translocation (-4245 AU; 95% CI -6765 to -1725). Intra-articular administration of imeglimin reduced histological severity of OA in cartilage, synovium, and meniscus in DMM+MCLT mice (OARSI grade, -3.0 [95% CI: -5.0 to -1.0]), decreased the number of cells expressing p-IκBα in the articular cartilage, and attenuated OA pain in both DMM+MCLT and MIA models. Imeglimin enhances protective functions in joint tissue cells and alleviates experimental OA in preclinical mouse models, supporting its potential as a therapeutic candidate for knee OA.

18 May 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MTMasakazu Toya
Masakazu Toya
YAYukio Akasaki
Yukio Akasaki
TSTakuya Sueishi
Takuya Sueishi
IKIchiro Kurakazu
Ichiro Kurakazu
MKMasanari Kuwahara
Masanari Kuwahara
YNYasuharu Nakashima
Yasuharu Nakashima
G protein-coupled receptor kinase 5 (GRK5) regulates inflammatory responses via the nuclear factor-kappa B (NF-κB) pathway. This study investigated the functional involvement of GRK5 in the pathogenesis of inflammatory arthritis. Immunohistochemically, rheumatoid arthritis (RA) synovium had a significantly higher proportion of GRK5-positive cells in the synovial lining layer than healthy control synovium. Gene expression and NF-κB activation in lipopolysaccharide-stimulated human SW982 synovial cells were significantly suppressed by silencing of the GRK5 gene. Similarly, GRK5 kinase activity inhibition in human primary RA synovial cells attenuated gene expressions of inflammatory factors. In a murine model of collagen antibody-induced arthritis, arthritis scores and serum IL6 production of GRK5 knockout (GRK5-/-) mice were significantly lower than those of wild-type mice. Histologically, the degree of synovitis and cartilage degeneration in GRK5-/- mice was significantly lower than in wild-type mice. In in vitro analyses using activated murine macrophages and fibroblast-like synoviocytes, gene expression of inflammatory factors and p65 nuclear translocation were significantly lower in GRK5-/- mice compared to wild-type mice. In conclusion, our results suggested that GRK5 is deeply involved in the pathogenesis of inflammatory arthritis, therefore, GRK5 inhibition could be a potential therapeutic target for types of inflammatory arthritis such as RA.

18 June 2026 in Arthroscopy Techniques
Verified
Journal Article
Open access
YAYukio Akasaki
Yukio Akasaki
IKIchiro Kurakazu
Ichiro Kurakazu
KKKenji Kitamura
Kenji Kitamura
SKShinya Kawahara
Shinya Kawahara
SHSatoshi Hamai
Satoshi Hamai
YNYasuharu Nakashima
Yasuharu Nakashima
Autologous bone grafting can enhance gap healing after medial open‐wedge high tibial osteotomy and open‐wedge distal tibial tuberosity osteotomy, but iliac‐crest harvest adds donor‐site morbidity and is therefore not routinely performed. We describe a bone autografting technique, termed cancellous autograft transfer from screw‐hole, which leverages routinely drilled locking plate screw pilot holes as a local donor source to obtain cancellous autograft without a separate donor‐site or additional incision. During plate fixation, cancellous bone is cored from the proximal screw pilot holes using a coring device (4.9 mm outer diameter, 4.5 mm inner lumen), and each harvested hole is then secured with a 5.5 mm locking screw. The cylindrical cores are transferred into the hinge‐side portion of the opening gap. In the initial 8 cases, mean cumulative core length is approximately 80 mm (range, 60‐130 mm), and computed tomography at 1 month shows early consolidation with bony bridging despite a lateral hinge fracture. The cancellous autograft transfer from screw‐hole technique is a simple adjunct to plate fixation that provides local cancellous autograft while fully avoiding donor‐site morbidity.

4 October 2026 in Journal of Autoimmunity
Verified
Journal Article
Open access
TNTakahiro Natori
Takahiro Natori
HYHisakata Yamada
Hisakata Yamada
RTRyosuke Tsurui
Ryosuke Tsurui
YAYukio Akasaki
Yukio Akasaki
SKShinya Kawahara
Shinya Kawahara
YNYasuharu Nakashima
Yasuharu Nakashima

18 August 2025 in Journal of Joint Surgery and Research
Verified
Journal Article
Open access
YAYukio Akasaki
Yukio Akasaki
SHSatoshi Hamai
Satoshi Hamai
SKShinya Kawahara
Shinya Kawahara
IKIchiro Kurakazu
Ichiro Kurakazu
KKKenji Kitamura
Kenji Kitamura
YNYasuharu Nakashima
Yasuharu Nakashima